TetraLogic Pharmaceuticals (TLOG) Short Interest Ratio & Short Volume

Short interest is the volume of TetraLogic Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 500 shares of TLOG short. 0.00% of TetraLogic Pharmaceuticals' shares are currently sold short. Learn More on TetraLogic Pharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of TetraLogic Pharmaceuticals' floating shares are currently sold short.

0.00% of TetraLogic Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "med - biomed/gene" compare to TetraLogic Pharmaceuticals: Cocrystal Pharma, Inc. (0.20%), CytoMed Therapeutics Limited (1.24%), Galapagos NV (2.95%), Pharma Mar (0.05%), POXEL FRANCE (0.00%), Pulmatrix, Inc. (0.60%), RegeneRx Biopharmaceuticals Inc. (0.01%), RenovaCare Inc. (0.00%), and

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling TLOG is an investing strategy that aims to generate trading profit from TetraLogic Pharmaceuticals as its price is falling. TLOG shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for TetraLogic Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TLOG, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLOG, twice per month. The most recent reporting period available is May, 31 2025.